ProShare Advisors
LMAT icon

ProShare Advisors’s LeMaitre Vascular LMAT Stock Holding History

ProShare Advisors’s Portfolio LMAT Stock Details LMAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.23M Buy
75,301
+14,323
+23% +$1.47M 0.01% 457
2026
Q1 		$6.66M Sell
60,978
-13,132
-18% -$1.25M 0.01% 446
2025
Q4 		$6.01M Buy
74,110
+6,403
+9% +$551K 0.01% 513
2025
Q3 		$5.93M Sell
67,707
-11,355
-14% -$1.01M 0.01% 518
2025
Q2 		$6.57M Sell
79,062
-12,721
-14% -$1.06M 0.01% 442
2025
Q1 		$7.7M Buy
91,783
+9,623
+12% +$895K 0.02% 388
2024
Q4 		$7.57M Sell
82,160
-1,105
-1% -$106K 0.02% 403
2024
Q3 		$7.73M Sell
83,265
-12,938
-13% -$1.12M 0.02% 410
2024
Q2 		$7.92M Sell
96,203
-17,708
-16% -$1.3M 0.02% 356
2024
Q1 		$7.56M Sell
113,911
-29,557
-21% -$1.82M 0.02% 426
2023
Q4 		$8.14M Buy
143,468
+2,993
+2% +$157K 0.02% 402
2023
Q3 		$7.65M Buy
140,475
+12,365
+10% +$733K 0.02% 392
2023
Q2 		$8.62M Sell
128,110
-59,013
-32% -$3.6M 0.03% 351
2023
Q1 		$9.63M Sell
187,123
-9,165
-5% -$445K 0.03% 335
2022
Q4 		$9.03M Buy
196,288
+35,659
+22% +$1.67M 0.03% 326
2022
Q3 		$8.14M Sell
160,629
-23,596
-13% -$1.18M 0.03% 303
2022
Q2 		$8.39M Sell
184,225
-30,435
-14% -$1.36M 0.03% 370
2022
Q1 		$9.97M Buy
214,660
+7,389
+4% +$331K 0.02% 424
2021
Q4 		$10.4M Buy
207,271
+43,213
+26% +$2.23M 0.02% 408
2021
Q3 		$8.71M Sell
164,058
-22,196
-12% -$1.25M 0.02% 418
2021
Q2 		$11.4M Buy
186,254
+181,317
+3,673% +$9.63M 0.03% 318
2021
Q1 		$241K Buy
+4,937
New +$231K ﹤0.01% 1928

Other funds holding LMAT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

ProShare Advisors's LMAT Position: Q2 2026 in Review

ProShare Advisors increased its LeMaitre Vascular (LMAT) stake by 23% in Q2 2026, buying an estimated $1.47M and bringing the position to 75,301 shares worth $7.23M. The position accounts for 0.01% of the portfolio, ranked #457.

ProShare Advisors first reported a position in LMAT in Q1 2021 and has held it in 22 quarters since. The position peaked at $11.4M in Q2 2021. 326 funds tracked by Wall St. Rank hold LMAT as of Q2 2026.

  • ProShare Advisors held 75,301 shares of LeMaitre Vascular worth $7.23M as of Q2 2026.
  • ProShare Advisors bought 14,323 LeMaitre Vascular shares in Q2 2026, an estimated $1.47M.
  • LeMaitre Vascular made up 0.01% of ProShare Advisors's portfolio in Q2 2026, its #457 holding.
  • ProShare Advisors first reported a position in LeMaitre Vascular in Q1 2021 and has held it in 22 quarters since.
  • ProShare Advisors's LeMaitre Vascular position peaked at $11.4M in Q2 2021.
  • 326 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2026.

Based on ProShare Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.